首页> 美国卫生研究院文献>Journal of Clinical Medicine >A Randomized Controlled Trial Evaluating Integrative Psychotherapeutic Group Treatment Compared to Self-Help Groups in Functional Vertigo/Dizziness
【2h】

A Randomized Controlled Trial Evaluating Integrative Psychotherapeutic Group Treatment Compared to Self-Help Groups in Functional Vertigo/Dizziness

机译:随机对照试验评估综合性心理治疗组治疗与功能眩晕/头晕的自助组相比

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We tested the efficacy of an integrative psychotherapeutic group treatment (IPGT) in reducing vertigo/dizziness-related impairment along with depression, anxiety, and somatization by conducting a randomized controlled superiority trial comparing IPGT to self-help groups moderated by a clinical psychologist (SHG). Adult patients with functional vertigo and dizziness symptoms were randomly allocated to either the IPGT or SHG as active control group. Outcomes were assessed at baseline (t0), after treatment lasting 16 weeks (t1), and 12 months after treatment (t2). A total of 81 patients were assigned to IPGT and 78 patients were assigned to SHG. Vertigo-related impairment was reduced in both conditions (IPGT: t0–t1: d = 1.10, t0–t2: d = 1.06; SHG: t0–t1: d = 0.86, t0–t2: d = 1.29), showing the efficiency of both IPGT and SHG. Clinically relevant improvements were also obtained for depression in both groups. Linear mixed model analyses revealed no differences between groups for all outcomes (effect of group for the primary outcome: b = −1.15, SE = 2.13, t = −0.54, p = 0.59). Attrition rates were higher in SHG (52.6%) than in IPGT (28.4%). Both conditions improved primary and secondary outcomes while IPGT was better accepted by patients than SHG. Trial registration: ClinicalTrials.gov, Identifier: {"type":"clinical-trial","attrs":{"text":"NCT02320851","term_id":"NCT02320851"}}NCT02320851.
机译:我们通过开展随机控制优势试验将IPGT与临床心理学家(SHG)调节的自助群体进行随机对照的优势试验,通过抑郁症,焦虑和躯体化以及抑郁症,焦虑和躯体化的抑郁症,焦虑和躯体化的疗效减少眩晕/头晕和躯体化的疗效。 )。成年患者随机分配有功能性眩晕和头晕症状,以IPGT或SHG作为活性对照组。在基线(T0)中评估结果,治疗持续16周(T1)和治疗后12个月(T2)。将81名患者分配给IPGT,78名患者分配给SHG。两个条件(IPGT:T0-T1:D = 1.10,T0-T2:D = 1.06; SHG:T0-T1:D = 0.86,T0-T2:D = 1.29),显示眩晕相关的损伤IPGT和SHG都有。两组抑郁症也得到了临床相关的改进。线性混合模型分析显示所有结果的群体之间没有差异(主要结果组的效果:B = -1.15,SE = 2.13,T = -0.54,P = 0.59)。 SHG的磨损率高于IPGT(52.6%)(28.4%)。这两种条件改善了初级和二次结果,而IPGT患者比SHG更好。试用注册:ClinicalTrials.gov,标识符:{“类型”:“临床试验”,“attrs”:{“text”:“nct02320851”,“term_id”:“nct02320851”}} nct02320851。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号